Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Insmed Incorporated, 3 years.
Insmed Incorporated
Director
X4 Pharmaceuticals Inc.
Director
Rhythm Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rhythm Pharmaceuticals Inc. June 24, 202685.9%
-
X4 Pharmaceuticals Inc. June 10, 202488.2%
-
Rhythm Pharmaceuticals Inc. June 21, 202392.0%
-
Insmed Incorporated May 11, 202388.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,712 | — | — |
| Feb 9, 2026 | Insmed Incorporated | Gift | −53,400 | — | — |
| Feb 9, 2026 | Insmed Incorporated | Gift | +53,400 | — | — |
| Jun 18, 2025 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,000 | — | — |
| Jun 9, 2025 | X4 Pharmaceuticals Inc. | Grant or award | +1,500 | — | — |
| Jun 4, 2025 | Insmed Incorporated | Open-market sale | −3,000 | $73.27 | $219,810 |
| Jun 3, 2025 | Rhythm Pharmaceuticals Inc. | Option exercise | +65,431 | $4.59 | $300,328 |
| Jun 3, 2025 | Insmed Incorporated | Open-market sale | −3,250 | $71.30 | $231,725 |
| Jun 3, 2025 | Rhythm Pharmaceuticals Inc. | Open-market sale | −55,558 | $65.15 | $3,619,604 |
| Jun 3, 2025 | Rhythm Pharmaceuticals Inc. | Open-market sale | −9,873 | $65.64 | $648,064 |
| May 15, 2025 | Insmed Incorporated | Grant or award | +5,058 | — | — |
| Jun 21, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +3,000 | — | — |
| Jun 10, 2024 | X4 Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
| May 13, 2024 | Insmed Incorporated | Grant or award | +13,162 | — | — |
| Jun 13, 2023 | X4 Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.